TN2011000134A1 - Polytherapie destinee a traiter une infection par le vhc - Google Patents

Polytherapie destinee a traiter une infection par le vhc

Info

Publication number
TN2011000134A1
TN2011000134A1 TN2011000134A TN2011000134A TN2011000134A1 TN 2011000134 A1 TN2011000134 A1 TN 2011000134A1 TN 2011000134 A TN2011000134 A TN 2011000134A TN 2011000134 A TN2011000134 A TN 2011000134A TN 2011000134 A1 TN2011000134 A1 TN 2011000134A1
Authority
TN
Tunisia
Prior art keywords
polytherapie
destinee
vhc
une infection
infection par
Prior art date
Application number
TN2011000134A
Other languages
English (en)
Inventor
Gerhard Gustav Steinmann
Jerry O Stern
David Huang
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2009/056771 external-priority patent/WO2010033443A1/fr
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of TN2011000134A1 publication Critical patent/TN2011000134A1/fr

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TN2011000134A 2009-09-14 2011-03-15 Polytherapie destinee a traiter une infection par le vhc TN2011000134A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2009/056771 WO2010033443A1 (fr) 2008-09-17 2009-09-14 Polythérapie destinée à traiter une infection par le vhc

Publications (1)

Publication Number Publication Date
TN2011000134A1 true TN2011000134A1 (en) 2012-09-05

Family

ID=55024422

Family Applications (1)

Application Number Title Priority Date Filing Date
TN2011000134A TN2011000134A1 (en) 2009-09-14 2011-03-15 Polytherapie destinee a traiter une infection par le vhc

Country Status (1)

Country Link
TN (1) TN2011000134A1 (fr)

Similar Documents

Publication Publication Date Title
MY152824A (en) Combination of hcv ns3 protease inhibitor with interferon and ribavirin.
MX2009009174A (es) Inhibidores de serina-proteasas para el tratamiento de infecciones por el virus de hepatitis c.
NZ599284A (en) Combinations of a specific hcv ns5a inhibitor and an hcv ns3 protease inhibitor
MX2009009176A (es) Inhibidores de serina-proteasas.
ES2572329A2 (es) Combinacion de al menos dos agentes antivirales de accion directa y ribavirina pero no interferon, para uso en el tratamientodel vhc
MY148123A (en) Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
WO2007016476A3 (fr) Inhibiteurs de la sérine protéase de l'hépatite c et emploi desdits inhibiteurs
JO2593B1 (en) Protease inhibitors NS3 hepatitis C HCV virus
TW200510391A (en) Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
MX2009004556A (es) Inhibidores de la proteasa ns3 del hcv.
SG159385A1 (en) Inhibitors of serine proteases, particularly hepatitis c virus ns3 - ns4 protease
MX2010006210A (es) Inhibidores de serina proteasa de hcv de tripeptido fluorado.
WO2005077969A3 (fr) Inhibiteurs de proteases serines, en particulier de la protease hcv ns3-ns4a
EA200900969A1 (ru) Макроциклические ингибиторы протеазы гепатита с
SG163517A1 (en) Antiviral compounds and methods
MX2013003634A (es) Derivados policiclicos heterociclicos y metodos de uso de los mismos para el tratamiento de enfermedades virales.
MX2013003060A (es) Terapia de combinacion para tratar infeccion por hcv.
WO2010034105A8 (fr) Composés inhibiteurs de l'hépatite c
MX2010008108A (es) Inhibidores de proteasa de serina de tripéptido de virus de hepatitis c (hcv) que contienen heteroarilo.
WO2008046860A3 (fr) Combinaisons biodisponibles pour le traitement du hcv
MX2013004906A (es) Nuevos inhibidores especificos de la proteasa ns3 de hcv.
UA90909C2 (en) Hcv ns3 protease inhibitors
WO2009067225A3 (fr) Peptides pour le traitement d'infections par le vhc
TN2011000134A1 (en) Polytherapie destinee a traiter une infection par le vhc
UA95990C2 (en) Hcv ns3 protease inhibitors